Cargando…
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
BACKGROUND: Kallistatin exerts beneficial effects on organ injury by inhibiting oxidative stress and inflammation. However, the role of kallistatin in atherosclerosis is largely unknown. Here, we investigated the role and mechanisms of kallistatin in patients with coronary artery disease (CAD), athe...
Autores principales: | Yao, Yuyu, Li, Bing, Liu, Chang, Fu, Cong, Li, Pengfei, Guo, Youming, Ma, Genshan, Liu, Naifeng, Chao, Lee, Chao, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404169/ https://www.ncbi.nlm.nih.gov/pubmed/30554563 http://dx.doi.org/10.1161/JAHA.118.009562 |
Ejemplares similares
-
Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017) -
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
por: Li, Pengfei, et al.
Publicado: (2015) -
Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013) -
Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression
por: Chao, Julie, et al.
Publicado: (2017) -
Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
por: Chao, Julie, et al.
Publicado: (2018)